EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Platelet Membrane-Based Nanoparticles for Targeted Delivery of Deferoxamine to Alleviate Brain Injury Induced by Ischemic Stroke

Peina Wang, Xin Lv, Siyu Tian, Wen Yang iD, Mudi Feng, Shiyang Chang, Linhao You, Yan-Zhong Chang

International Journal of Nanomedicine · 2025

DOI: 10.2147/ijn.s516316 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2025. Verfasst von Peina Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Iron Metabolism, Key Laboratory of Animal Physiology, Biochemistry and Molecular Biology of Hebei Province, Ministry of Educa…. Hauptthemen laut MEDLINE: Deferoxamine, Nanoparticles, Ischemic Stroke, Blood Platelets. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Timely thrombolysis serves as the primary therapeutic approach for ischemic stroke, one of the most serious global public health problems, although reperfusion can cause severe ischemia reperfusion (I/R) injury. Oxidative stress and activation of cell death pathways are the main mechanisms of I/R injury. Our previous studies have demonstrated that iron overload stimulates the generation of reactive oxygen species and facilitates the activation of iron-dependent ferroptosis in the pathogenesis of I/R injury. Removal of excess free iron by deferoxamine (DFO), an iron chelator, may inhibit iron toxicity and reverse I/R-induced neurological deficits. Despite its therapeutic potential, DFO's clinical translation for I/R injury is hampered by rapid systemic clearance, suboptimal bioavailability, and a lack of ischemic lesion-targeting ability. Nanoscale delivery platforms enabling targeted DFO release in stroke lesions may overcome these pharmacokinetic barriers and enhance clinical outcomes.

Methods

On the basis of the properties of liposomes in carrying hydrophilic substances and crossing the leaky blood-brain barrier in cerebral I/R, we first encapsulated DFO within traditional liposomes to improve its biocompatibility. Subsequently, inspired by the natural homing properties of platelets to damaged blood vessels during I/R injury, the isolated platelet membranes were coated onto the DFO-liposomes, thus endowing the nanodrug with the ability to target stroke lesion.

Results

Our results demonstrate that Platesome-DFO exhibits accurate lesion-targeting ability and significantly decreases lesion iron content, thereby preventing neuronal ferroptosis and ultimately reversing neurological deficits in I/R mice.

Conclusion

Platesome-DFO provides a novel therapeutic approach for cerebral I/R injury by regulating brain iron status and iron-dependent pathways, highlighting its promising application in the clinical treatment of cerebral I/R injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DeferoxamineNanoparticlesIschemic StrokeBlood PlateletsBrain InjuriesAnimalsMiceMaleLiposomesReperfusion InjuryBlood-Brain BarrierMice, Inbred C57BLIronHumansDrug Delivery SystemsFerroptosis

Stichwörter der Autor:innen

deferoxamineferroptosisironischemic strokenanomedicineplatelet membrane

Substanzen

DeferoxamineLiposomesIron

Autor:innen und Institutionen

  • Laboratory of Molecular Iron Metabolism, Key Laboratory of Animal Physiology, Biochemistry and Molecular Biology of Hebei Province, Ministry of Education Key Laboratory of Molecular and Cellular Biology, Department of P…
  • Department of Histology and Embryology, College of Basic Medical Sciences, Hebei Medical University, Shijiazhuang, Hebei Province, 050017, People's Republic of China.

ORCID-Profile: Wen Yang

Zitieren

APA

Wang, P., Lv, X., Tian, S., Yang, W., Feng, M., Chang, S., You, L., & Chang, Y. Z. (2025). Platelet Membrane-Based Nanoparticles for Targeted Delivery of Deferoxamine to Alleviate Brain Injury Induced by Ischemic Stroke. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s516316

Vancouver

Wang P, Lv X, Tian S, Yang W, Feng M, Chang S, et al. Platelet Membrane-Based Nanoparticles for Targeted Delivery of Deferoxamine to Alleviate Brain Injury Induced by Ischemic Stroke. International Journal of Nanomedicine. 2025. doi:10.2147/ijn.s516316

BibTeX
@article{Wang2025,
  author = {Wang, Peina and Lv, Xin and Tian, Siyu and Yang, Wen and Feng, Mudi and Chang, Shiyang and You, Linhao and Chang, Yan-Zhong},
  title = {Platelet Membrane-Based Nanoparticles for Targeted Delivery of Deferoxamine to Alleviate Brain Injury Induced by Ischemic Stroke},
  journal = {International Journal of Nanomedicine},
  year = {2025},
  doi = {10.2147/ijn.s516316}
}
Kostenlos starten →